A growing number of decisions illustrate the divergences of solutions which can exist between the various national courts with respect to the various national designations of a same European patent.…
In a judgment of 11 December 2009, the Commercial Court of Antwerp invalidated the Belgian part of EP 0 663 828 of Sepracor for lack of inventive step. This patent claims the use of the active…
German courts (and German attorneys) have been quite creative to improve the position of the patentee in litigation in the past. Last year the Olanzapine- decision of the Appeals Court in Düsseldorf…
One of the topics most hotly discussed before the Spanish Courts over the last few years is whether the legal effects of the TRIPS' provisions on patents are governed by Community law or by the…
The “nail-Byting” in the Computer IP community came to an end on 12 May 2010 when the EPO’s Enlarged Board of Appeal finally handed down its opinion in the “Programs for Computers” case. The opinion…
By decision no. 6967/2009 of 14 May 2009, the IP Chamber of the Court of Milan found for the invalidity of a patent claiming the second medical use of a known pharmaceutical product for lack of…
The grant of supplementary protection certificates (SPCs) has been the subject of numerous recent cases in Europe. In the UK, the latest development in Neurim Pharmaceuticals (1991) Limited v.…
On the basis of a use patent, Aventis filed for interim relief against Hospira at the Bailiff’s Court (Enforcement court) at Lyngby City Court in Denmark. The claim was based on DK/EP 0593656 and…
I have to start this with a simple introduction into container technology:
This is an intermediate bulk container (IBC):
In principle such an IBC consists of three elements, the base, the…
One of the new question marks introduced by Directive 2004/48 (the so-called "Enforcement Directive") is what amount of indicia is required to prove that an act of infringement is "imminent" for the…
